Last Updated: November 8, 2026

Details for New Drug Application (NDA): 210549

« Back to Dashboard

NDA 210549 describes AZELAIC ACID, which is a drug marketed by Aurobindo Pharma Usa, Actavis Labs Ut Inc, Encube, Glenmark Speclt, and Sun Pharma Canada, and is included in five NDAs. It is available from five suppliers. Additional details are available on the AZELAIC ACID profile page.

The generic ingredient in AZELAIC ACID is azelaic acid. There is one drug master file entry for this compound. Eight suppliers are listed for this compound. Additional details are available on the azelaic acid profile page.

Summary for 210549

Tradename:	AZELAIC ACID
Applicant:	Sun Pharma Canada
Ingredient:	azelaic acid
Patents:	0

Pharmacology for NDA: 210549

Physiological Effect	Decreased Protein Synthesis Decreased Sebaceous Gland Activity

Suppliers and Packaging for NDA: 210549

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
AZELAIC ACID	azelaic acid	GEL;TOPICAL	210549	ANDA	Sun Pharmaceutical Industries, Inc.	51672-1389	51672-1389-3	1 TUBE in 1 CARTON (51672-1389-3) / 50 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	GEL;TOPICAL			Strength	15%
Approval Date:	Aug 23, 2019	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.